{"id":194355,"date":"2026-08-10T15:23:36","date_gmt":"2026-08-10T09:53:36","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=194355"},"modified":"2026-08-10T15:23:38","modified_gmt":"2026-08-10T09:53:38","slug":"pros-cons-investing-star-share","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/","title":{"rendered":"Strides Pharma Science Share: Pros and Cons Every Investor Must Know in 2026"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Strides Pharma Science share CMP approx Rs 1,100. 52-week high Rs 1,420, low Rs 680. Market Cap Rs 10,450 Cr. P\/E ratio 35.42x.<\/em><\/p>\n<div style=\"background: #F0F7FF; border-left: 4px solid #1F4E79; border-radius: 6px; padding: 14px 18px; margin: 18px 0;\">\n<p style=\"margin: 0 0 8px 0; font-weight: bold; color: #1f4e79;\">Quick Answer<\/p>\n<ul style=\"margin: 0; padding-left: 20px; color: #333;\">\n<li>Strides Pharma share at 35.42x PE \u2014 regulated markets pharma exporter with complex portfolio and below-quality ROE<\/li>\n<li>Exports soft gelatin capsules and specialty oral dosage forms to US, Australia, UK, and Africa<\/li>\n<li>Key concern: ROE 12.96% below quality pharma benchmark; multiple restructurings create complexity discount<\/li>\n<\/ul>\n<\/div>\n<p>Is the Strides Pharma Science share a good investment in 2026? This article provides a data-driven analysis of Strides Pharma Science share pros and cons \u2014 covering business strengths, valuation, growth drivers, and key risks \u2014 based on live data from 7 August 2026.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=strides-pharma-pros-cons\"><strong>Click Here \u2014 Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#About_Strides_Pharma_Science\" title=\"About Strides Pharma Science\">About Strides Pharma Science<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#Key_Financial_Snapshot_Strides_Pharma_Science_Share\" title=\"Key Financial Snapshot: Strides Pharma Science Share\">Key Financial Snapshot: Strides Pharma Science Share<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#Top_5_Pros_of_Strides_Pharma_Science_Share\" title=\"Top 5 Pros of Strides Pharma Science Share\">Top 5 Pros of Strides Pharma Science Share<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#1_Softgel_Capsule_Specialty_%E2%80%94_Technical_Differentiation_in_Complex_Oral_Dosage\" title=\"1. Softgel Capsule Specialty \u2014 Technical Differentiation in Complex Oral Dosage\">1. Softgel Capsule Specialty \u2014 Technical Differentiation in Complex Oral Dosage<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#2_US_ANDA_Pipeline_%E2%80%94_Specialty_Oral_Dosage_Forms_With_Better_Price_Sustainability\" title=\"2. US ANDA Pipeline \u2014 Specialty Oral Dosage Forms With Better Price Sustainability\">2. US ANDA Pipeline \u2014 Specialty Oral Dosage Forms With Better Price Sustainability<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#3_Australia_Market_Leadership_%E2%80%94_Strides_is_One_of_Australias_Largest_Generic_Suppliers\" title=\"3. Australia Market Leadership \u2014 Strides is One of Australia&#8217;s Largest Generic Suppliers\">3. Australia Market Leadership \u2014 Strides is One of Australia&#8217;s Largest Generic Suppliers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#4_UK_and_Africa_Branded_Generic_Expansion_%E2%80%94_International_Revenue_Diversification\" title=\"4. UK and Africa Branded Generic Expansion \u2014 International Revenue Diversification\">4. UK and Africa Branded Generic Expansion \u2014 International Revenue Diversification<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#5_Arun_Kumar_Founder-Promoter_Drive_%E2%80%94_Serial_Pharma_Entrepreneur_Creating_Value\" title=\"5. Arun Kumar Founder-Promoter Drive \u2014 Serial Pharma Entrepreneur Creating Value\">5. Arun Kumar Founder-Promoter Drive \u2014 Serial Pharma Entrepreneur Creating Value<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#Key_Cons_of_Strides_Pharma_Science_Share\" title=\"Key Cons of Strides Pharma Science Share\">Key Cons of Strides Pharma Science Share<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#1_ROE_of_1296_Percent_Below_Quality_Pharma_Benchmark_%E2%80%94_Complex_History_Depressing_Returns\" title=\"1. ROE of 12.96 Percent Below Quality Pharma Benchmark \u2014 Complex History Depressing Returns\">1. ROE of 12.96 Percent Below Quality Pharma Benchmark \u2014 Complex History Depressing Returns<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#2_Complex_Corporate_History_%E2%80%94_Multiple_Restructurings_Creating_Investor_Confidence_Gap\" title=\"2. Complex Corporate History \u2014 Multiple Restructurings Creating Investor Confidence Gap\">2. Complex Corporate History \u2014 Multiple Restructurings Creating Investor Confidence Gap<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#3_US_Generic_Market_Price_Erosion_%E2%80%94_Commodity_Oral_Solid_Competition\" title=\"3. US Generic Market Price Erosion \u2014 Commodity Oral Solid Competition\">3. US Generic Market Price Erosion \u2014 Commodity Oral Solid Competition<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#4_3542x_PE_For_1296_Percent_ROE_%E2%80%94_Valuation_Tension_Requiring_Turnaround_Delivery\" title=\"4. 35.42x PE For 12.96 Percent ROE \u2014 Valuation Tension Requiring Turnaround Delivery\">4. 35.42x PE For 12.96 Percent ROE \u2014 Valuation Tension Requiring Turnaround Delivery<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#Is_Strides_Pharma_Science_Share_a_Good_Investment_in_2026\" title=\"Is Strides Pharma Science Share a Good Investment in 2026?\">Is Strides Pharma Science Share a Good Investment in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#Key_Risks_Before_Buying_Strides_Pharma_Science_Share\" title=\"Key Risks Before Buying Strides Pharma Science Share\">Key Risks Before Buying Strides Pharma Science Share<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#Frequently_Asked_Questions_%E2%80%94_Strides_Pharma_Science_Share\" title=\"Frequently Asked Questions \u2014 Strides Pharma Science Share\">Frequently Asked Questions \u2014 Strides Pharma Science Share<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#What_are_the_main_pros_of_Strides_Pharma_share\" title=\"What are the main pros of Strides Pharma share?\">What are the main pros of Strides Pharma share?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#What_are_the_risks\" title=\"What are the risks?\">What are the risks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#Is_Strides_Pharma_share_a_good_investment\" title=\"Is Strides Pharma share a good investment?\">Is Strides Pharma share a good investment?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#What_is_the_52-week_range\" title=\"What is the 52-week range?\">What is the 52-week range?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#What_are_softgel_capsules_and_why_is_Strides_softgel_manufacturing_a_differentiator\" title=\"What are softgel capsules and why is Strides&#8217; softgel manufacturing a differentiator?\">What are softgel capsules and why is Strides&#8217; softgel manufacturing a differentiator?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/pros-cons-investing-star-share\/#What_happened_with_Agila_Pharmaceuticals_and_how_did_it_impact_Strides\" title=\"What happened with Agila Pharmaceuticals and how did it impact Strides?\">What happened with Agila Pharmaceuticals and how did it impact Strides?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Strides_Pharma_Science\"><\/span><strong>About Strides Pharma Science<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Strides Pharma Science Limited (NSE: STAR) is a Bengaluru-based pharmaceutical company founded in 1990 by Arun Kumar. It exports specialty oral dosage formulations \u2014 particularly soft gelatin capsules (softgels), controlled release tablets, and complex oral solids \u2014 to the US, Australia, UK, South Africa, and other regulated markets. Strides has a complex corporate history involving multiple subsidiaries, stake sales, and restructurings \u2014 including the sale of its injectable division (Agila Pharmaceuticals to Mylan in 2013) and various emerging market subsidiary reorganisations.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Financial_Snapshot_Strides_Pharma_Science_Share\"><\/span><strong>Key Financial Snapshot: Strides Pharma Science Share<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Parameter<\/th>\n<th>Details<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Company<\/td>\n<td><a href=\"https:\/\/univest.in\/stocks\/star\/strides-pharma-science-ltd-share-price-today\">Strides Pharma Science<\/a><\/td>\n<\/tr>\n<tr>\n<td>NSE Symbol<\/td>\n<td>STAR<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharma Regulated Markets Export<\/td>\n<\/tr>\n<tr>\n<td>CMP (Approx)<\/td>\n<td>Rs 1,100<\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 1,420<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 680<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 10,450 Cr<\/td>\n<\/tr>\n<tr>\n<td>P\/E Ratio<\/td>\n<td>35.42x<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Data approximate. Verify at <a href=\"https:\/\/www.nseindia.com\" rel=\"nofollow noopener\" target=\"_blank\">nseindia.com<\/a>.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Top_5_Pros_of_Strides_Pharma_Science_Share\"><\/span><strong>Top 5 Pros of Strides Pharma Science Share<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_Softgel_Capsule_Specialty_%E2%80%94_Technical_Differentiation_in_Complex_Oral_Dosage\"><\/span><strong>1. Softgel Capsule Specialty \u2014 Technical Differentiation in Complex Oral Dosage<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Strides Pharma&#8217;s specialty in soft gelatin capsule manufacturing provides technical differentiation from standard tablet-only API manufacturers. Softgels are technically challenging to manufacture and have fewer FDA-approved filers than standard tablets \u2014 providing better generic pricing durability.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_US_ANDA_Pipeline_%E2%80%94_Specialty_Oral_Dosage_Forms_With_Better_Price_Sustainability\"><\/span><strong>2. US ANDA Pipeline \u2014 Specialty Oral Dosage Forms With Better Price Sustainability<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Strides Pharma&#8217;s US ANDA pipeline focuses on complex oral dosage forms (softgels, controlled release) where fewer generic filers and higher technical barriers provide better pricing sustainability than commodity tablet generics.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Australia_Market_Leadership_%E2%80%94_Strides_is_One_of_Australias_Largest_Generic_Suppliers\"><\/span><strong>3. Australia Market Leadership \u2014 Strides is One of Australia&#8217;s Largest Generic Suppliers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Strides has strong Australia market presence \u2014 one of the largest generic pharmaceutical suppliers to Australian pharmacies. Australia&#8217;s regulated generic pharmaceutical market provides stable, predictable revenue from long-term supply agreements.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_UK_and_Africa_Branded_Generic_Expansion_%E2%80%94_International_Revenue_Diversification\"><\/span><strong>4. UK and Africa Branded Generic Expansion \u2014 International Revenue Diversification<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Strides is growing branded generic sales in UK and Africa \u2014 adding international branded revenue alongside regulated market commodity generic supply for geographic diversification.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_Arun_Kumar_Founder-Promoter_Drive_%E2%80%94_Serial_Pharma_Entrepreneur_Creating_Value\"><\/span><strong>5. Arun Kumar Founder-Promoter Drive \u2014 Serial Pharma Entrepreneur Creating Value<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Arun Kumar is a serial pharmaceutical entrepreneur who has created significant shareholder value through Strides&#8217; previous divisions (Agila Pharmaceuticals sold to Mylan for Rs 2,500-plus crore). This founder-entrepreneur drive provides strategic initiative in identifying specialty pharmaceutical opportunities.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Cons_of_Strides_Pharma_Science_Share\"><\/span><strong>Key Cons of Strides Pharma Science Share<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_ROE_of_1296_Percent_Below_Quality_Pharma_Benchmark_%E2%80%94_Complex_History_Depressing_Returns\"><\/span><strong>1. ROE of 12.96 Percent Below Quality Pharma Benchmark \u2014 Complex History Depressing Returns<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At 12.96 percent ROE with debt-to-equity of 0.47x, Strides Pharma is below quality pharmaceutical benchmarks \u2014 reflecting the complexity discount from multiple corporate restructurings, remaining debt from acquisition integration, and the transition period between divested and new pharmaceutical businesses.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Complex_Corporate_History_%E2%80%94_Multiple_Restructurings_Creating_Investor_Confidence_Gap\"><\/span><strong>2. Complex Corporate History \u2014 Multiple Restructurings Creating Investor Confidence Gap<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Strides Pharma&#8217;s history of subsidiary sales, spin-offs, and restructurings has created a complex corporate narrative that makes institutional investors cautious about long-term strategic consistency. This complexity discount suppresses the PE multiple versus simpler, more focused pharmaceutical peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_US_Generic_Market_Price_Erosion_%E2%80%94_Commodity_Oral_Solid_Competition\"><\/span><strong>3. US Generic Market Price Erosion \u2014 Commodity Oral Solid Competition<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Strides&#8217; US ANDA portfolio faces commodity generic price erosion as multiple filers compete in standard tablet and capsule markets. Despite softgel differentiation, standard oral solid products face significant US generic price erosion.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_3542x_PE_For_1296_Percent_ROE_%E2%80%94_Valuation_Tension_Requiring_Turnaround_Delivery\"><\/span><strong>4. 35.42x PE For 12.96 Percent ROE \u2014 Valuation Tension Requiring Turnaround Delivery<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At 35.42x PE for 12.96 percent ROE, Strides Pharma share is moderately expensive for a company with below-quality return metrics. The PE implies significant ROE improvement delivery through Australia growth, US softgel expansion, and debt reduction.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Use the Univest Screener to Analyse Stocks for Free<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Is_Strides_Pharma_Science_Share_a_Good_Investment_in_2026\"><\/span><strong>Is Strides Pharma Science Share a Good Investment in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Strides Pharma share is a specialty pharmaceutical export investment with softgel technical differentiation and Australia market strength. Complex corporate history and below-quality ROE are constraints. Consider as small specialised pharma allocation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_Before_Buying_Strides_Pharma_Science_Share\"><\/span><strong>Key Risks Before Buying Strides Pharma Science Share<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>US generic oral solid pricing deterioration compressing softgel margins along with standard tablets<\/li>\n<li>Australia generic pharmaceutical market consolidation reducing Strides supply agreements<\/li>\n<li>Debt-to-equity 0.47x creating financial cost burden in rising interest rate environment<\/li>\n<li>USFDA warning letter on any Strides facility disrupting US regulated market supply<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Strides Pharma Science share offers softgel capsule specialty \u2014 technical differentiation in complex oral dosage as its primary investment case. Weigh it against roe of 12.96 percent below quality pharma benchmark \u2014 complex history depressing returns and the risks above before investing. Use the Univest Screener and consult a SEBI-registered advisor.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stock-market-research\/id1576403520\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.stockmarket\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Strides Pharma Science share price live.<\/em><\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data from publicly available sources. Approximate as of 7 Aug 2026. Verify on nseindia.com and bseindia.com. Not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_%E2%80%94_Strides_Pharma_Science_Share\"><\/span><strong>Frequently Asked Questions \u2014 Strides Pharma Science Share<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_pros_of_Strides_Pharma_share\"><\/span><strong>What are the main pros of Strides Pharma share?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Softgel capsule specialty with technical differentiation from standard tablet pharma, US ANDA pipeline in complex oral dosage with better pricing durability, Australia market leadership with stable supply agreements, UK and Africa branded generic diversification, and Arun Kumar founder-entrepreneur value creation drive.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks\"><\/span><strong>What are the risks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ROE 12.96% below quality pharma benchmark, complex corporate history creating institutional investor confidence gap, US generic price erosion despite softgel differentiation, and 35.42x PE requiring turnaround ROE delivery. Monitor quarterly Australia revenue and US ANDA approval pipeline.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Strides_Pharma_share_a_good_investment\"><\/span><strong>Is Strides Pharma share a good investment?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Specialty pharma exporter with softgel differentiation at moderate PE. Consider as small specialised pharma allocation. Consult a SEBI-registered advisor. Not investment advice.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52-week_range\"><\/span><strong>What is the 52-week range?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> 52-week high approximately Rs 1,420, low Rs 680. Current Rs 1,100. Verify at nseindia.com.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_softgel_capsules_and_why_is_Strides_softgel_manufacturing_a_differentiator\"><\/span><strong>What are softgel capsules and why is Strides&#8217; softgel manufacturing a differentiator?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Soft gelatin capsules (softgels) are liquid or semi-solid pharmaceutical formulations enclosed in a gelatine shell \u2014 used for drugs that are poorly water-soluble (improved bioavailability in softgel form), oils (fish oil supplements), or where precise liquid dosing is required (Vitamin E, Vitamin D, pain gels). Softgel manufacturing requires specialised encapsulation equipment (Accogel, rotary die encapsulators), strict temperature and humidity control, and different QC compared to standard tablet compression. Fewer pharmaceutical companies have softgel manufacturing capabilities \u2014 creating better generic pricing versus standard tablet markets with many filers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_happened_with_Agila_Pharmaceuticals_and_how_did_it_impact_Strides\"><\/span><strong>What happened with Agila Pharmaceuticals and how did it impact Strides?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Agila Pharmaceuticals was Strides&#8217; injectable pharmaceutical subsidiary \u2014 one of India&#8217;s largest sterile injectable manufacturers. Strides sold Agila to Mylan (now Viatris) in 2013 for approximately Rs 2,500-plus crore \u2014 one of the largest Indian pharmaceutical transactions. The sale generated significant cash that Strides used for other acquisitions and debt reduction. However, post-Agila, Strides needed to rebuild its pharmaceutical business around the remaining oral dosage and regulated market operations \u2014 leading to the multiple restructurings that created the complex corporate history investors now discount.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Strides Pharma share pros and cons: specialty regulated markets pharmaceutical exporter with softgel differentiation at 35.42x PE with complex corporate history analysed for 2026.<\/p>\n","protected":false},"author":28,"featured_media":194353,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-194355","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["194353"],"_edit_lock":["1786355621:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["70"],"rank_math_title":["Strides Pharma Share Pros and Cons 2026 | STAR Regulated Markets Export"],"rank_math_description":["Strides Pharma share pros and cons: regulated markets pharmaceutical exporter at 35.42x PE with 12.96% ROE versus below-quality ROE and complex acquisition integration."],"rank_math_focus_keyword":["Strides Pharma Share"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["35490"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/pros-cons-investing-star-share.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/194355","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=194355"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/194355\/revisions"}],"predecessor-version":[{"id":194370,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/194355\/revisions\/194370"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/194353"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=194355"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=194355"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=194355"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}